Lipid Synthesis: Building Cholesterol from Acetyl-CoA

Everything in lipid synthesis begins with a single two-carbon unit, acetyl-CoA, and from that one starting point the cell builds three completely different kinds of molecules. It can pour carbons into storage fats, the triacylglycerols that bank energy. It can route them into membranes, the phospholipids and sphingolipids that wrap every cell. Or it can elaborate them into hormones and signaling molecules like cholesterol and steroids. The same carbons, three destinations. What decides the fate is not the raw material but the regulatory switches: whether you are fed or fasting, flush with energy or starving, and how much cholesterol you already hold.

Phosphatidate is the single intersection where lipid synthesis splits. Picture a Y in the road. Coming up from the bottom is phosphatidate itself, a glycerol backbone carrying two fatty-acyl chains and a phosphate. From here the molecule faces a binary decision. Turn one way and the phosphate comes off, sending it toward storage as triacylglycerol, the cell's fat depot. Turn the other way and a polar head group is installed, building the phospholipids that form membranes. One molecule, two choices, many downstream fates. Hold this hub in mind, because every regulatory story later in the chapter is really about which arm of this fork gets favored.

Watch the actual chemistry of the fork. Phosphatidate can lose its phosphate group, producing diacylglycerol, which then accepts a third fatty acid to become triacylglycerol, a dense, anhydrous fuel reserve. Alternatively, phosphatidate is activated and coupled to an alcohol head group through a CDP-diacylglycerol intermediate, yielding a phospholipid destined for membranes. Losing the phosphate is a straightforward hydrolysis, while forming CDP-diacylglycerol spends a CTP and releases pyrophosphate, whose hydrolysis pulls that route forward instead. When the cell needs to bank calories it pushes toward fat. When it needs to grow membrane it pushes toward phospholipid. One precursor, two enzymatic exits, and the balance between them is tightly controlled.

Cholesterol is an enormous biosynthetic feat. Every one of its twenty-seven carbons traces back to the same humble two-carbon unit, acetyl-CoA. Eighteen acetyl-CoA molecules are pooled and condensed, and twenty-seven of those carbons are retained in the final sterol. The assembly happens in three broad stages and roughly thirty enzymatic steps: first building activated isoprene units, then chaining them into the thirty-carbon squalene, then folding and trimming squalene into cholesterol. The takeaway is conceptual, not arithmetic. A molecule this structurally rich is built entirely from small, identical bricks, which is exactly why its synthesis is so energetically expensive and so heavily regulated.

HMG-CoA reductase is the rate-limiting enzyme of cholesterol synthesis and the target of statins, so the cell guards it with four independent control layers operating on different timescales. Fastest is phosphorylation by AMPK, which switches the enzyme off within seconds to minutes when energy is low. Slower is translational control, where mevalonate-derived products suppress the messenger RNA over minutes to hours. Slower still is transcriptional control through SREBP, tuning enzyme amount over hours. And finally, sterol-induced degradation accelerates destruction of the protein itself. Four dials, one enzyme. Cholesterol is essential but toxic in excess, so the cell never relies on a single switch.

Think of cholesterol synthesis as a thermostat with two sensors feeding one dial. SREBP senses cholesterol itself: when the membrane runs low on cholesterol, SREBP turns synthesis up. AMPK senses energy: when ATP runs low and AMP rises, AMPK turns synthesis down because you should not spend fuel building expensive molecules during a famine. The two inputs converge on a single setpoint, balancing supply against both demand and affordability. High cholesterol pushes the needle toward less synthesis; low energy does the same for a different reason. Together the two signals swing HMG-CoA reductase activity across a more than 200-fold range, from full famine shutdown to full sterol-starved output.

AMPK is the cell's low-fuel warning light, and it reads the AMP to ATP ratio directly. When that ratio climbs, signaling a low-energy state, AMPK becomes active and starts phosphorylating the expensive biosynthetic enzymes. It shuts down HMG-CoA reductase, halting cholesterol synthesis, and it inactivates acetyl-CoA carboxylase, halting fatty-acid synthesis. The logic is blunt and sensible: do not spend ATP building storage and membrane molecules when you do not have ATP to spare. This is metabolic triage. Energy charge is monitored continuously, and the moment reserves dip, AMPK pulls the brake on anabolism across multiple pathways at once.

Cholesterol and triacylglycerols are oily and refuse to dissolve in blood, so the body ships them inside lipoproteins, which work like a lipid taxi with a protein driver. The core holds the hydrophobic cargo, triacylglycerols and cholesteryl esters, kept dry and away from water. Wrapping that core is a single shell of phospholipids with their polar heads facing outward, plus free cholesterol tucked among them. Riding on the surface are apolipoproteins, like apoB-100, which act as address labels and structural anchors. This simple architecture solves a hard transport problem: how to move greasy molecules through a watery bloodstream without them clumping.

Cells acquire cholesterol by capturing whole LDL particles in a five-step uptake cycle. First, apoB-100 on the LDL surface binds the LDL receptor at the cell surface. Second, the bound complexes cluster into coated pits lined with clathrin. Third, the pit pinches off into an internal vesicle. Fourth, the vesicle matures into an endosome where the acidic environment releases LDL from its receptor. Fifth, the cargo is delivered: LDL goes to the lysosome to be disassembled into free cholesterol, while the receptor is recycled back to the surface for another round. Receptors are reused; cargo is broken down. This recycling logic is exactly what familial hypercholesterolemia disrupts.

The damage in atherosclerosis is not done by native LDL but by oxidized LDL, and the sequence unfolds in four steps. First, LDL trapped in the artery wall becomes chemically oxidized. Second, macrophages take up this oxidized LDL through scavenger receptors that, unlike the normal LDL receptor, are not switched off by cholesterol load. Third, the engorged macrophages become foam cells, inflamed and secreting cytokines. Fourth, foam cells accumulate into a plaque that can rupture, triggering a thrombus, a clot, and a heart attack. The key conceptual twist is that the body's own cleanup cells, lacking a shut-off signal, gorge themselves into the disease.

Cholesterol is far more than a membrane stiffener; it is the master precursor for an entire family of essential molecules. From the same sterol ring system the body carves out bile salts, which emulsify dietary fats for absorption. It builds the steroid hormones that govern reproduction, stress, and metabolism. It makes vitamin D, supporting calcium absorption and bone health. And through the shared isoprenoid pathway it contributes to membrane anchors and cofactors like coenzyme Q. The unifying idea is that a single molecule wears many identities. Whatever you may have heard about cholesterol as a villain, life simply cannot run without it.

How does one cholesterol scaffold become five different steroid hormones? The answer is cytochrome P450, an oxygen-adding machine. Using molecular oxygen and NADPH, P450 enzymes insert hydroxyl groups at specific positions on the steroid skeleton, and the position of that single hydroxyl determines the molecule's function. A hydroxyl at one carbon yields a glucocorticoid like cortisol; modification elsewhere produces androgens; a further oxidation step opens the path to estrogens. One scaffold, many hormones, all distinguished by where the oxygen lands. This is precision chemistry: tiny, regiospecific edits to a shared backbone generate hormones with profoundly different physiological roles.

Isopentenyl pyrophosphate, IPP, is nature's favorite five-carbon building block, and following it reveals how one small unit seeds an astonishing range of molecules. Chain IPP units together and you can build cholesterol and steroid hormones, coenzyme Q for the electron transport chain, dolichol for glycoprotein assembly, vitamin K for blood clotting, beta-carotene and the vitamins derived from it, and even natural rubber. One five-carbon brick, six universes of molecules. The lesson is that biology is endlessly economical: it reuses a single activated isoprene over and over, varying only how many it strings together and how it folds them, to populate vast chemical territory.